MedTrace Logo

Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy

NCT04275882 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 886

Last updated 2022-03-08

No results posted yet for this study

Summary

Left ventricular hypertrophy (LVH) is the most common result of the heart trying to pump blood against the high afterload, as in hypertension and aortic stenosis.Although hypertension is the most common cause of LVH, LVH can also be found in athletes and cardiomyopathies or in storage disorders such as amyloidosis. In addition, genetic diseases also play an important role in the pathogenesis of LVH. Fabry disease is another disease that should be considered in patients with left ventricular hypertrophy.Left ventricular hypertrophy is a common and potentially modifiable cardiovascular risk factor that is frequently overlooked in clinical practice.The benefit of combining ECG and echocardiography in the diagnosis of LVH has been demonstrated.Early diagnosis and treatment-related regression of LVH, reduces adverse cardiovascular events and improves survival.Therefore, the investigators planned to perform a retrospective, observational LVH-TR study in order to determine the etiologic causes of LVH, the symptoms presented by the patients, and the effects of patients' demographic characteristics on LVH.

Conditions

  • Left Ventricular Hypertrophy

Interventions

DIAGNOSTIC_TEST

Electrocardiogram

There will be no new intervention performed for the patients.

Sponsors & Collaborators

  • Cardiovascular Academy Society, Turkey

    lead OTHER

Principal Investigators

  • mehmet kış, dr · turkey

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-14
Primary Completion
2021-09-01
Completion
2021-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04275882 on ClinicalTrials.gov